LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab

Yahua Wua Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, P.R. ChinaView further author information

Bin Dua Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, P.R. ChinaView further author information

Chengliu Lva Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, P.R. ChinaView further author information

Xiaohui Jib Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, P.R. ChinaView further author information

Jinhuo Laia Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, P.R. ChinaCorrespondence[email protected]
View further author information

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.